EMA Application withdrawn: Tidhesco (Ivosidenib) — Les Laboratoires Servier

View source ↗

Summary

The EMA withdrew the application for Tidhesco (ivosidenib) by Les Laboratoires Servier for acute myeloid leukemia therapeutic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tidhesco (ivosidenib)

Snippet

Status: Application withdrawn. Therapeutic area: Leukemia, Myeloid, Acute. MAH: Les Laboratoires Servier. Orphan medicine